open access

Vol 62, No 4 (2011)
Original papers
Published online: 2011-08-30
Submitted: 2013-02-15
Get Citation

Higher 11-beta-hydroxysteroid dehydrogenase type I gene expression in white adipose tissue in male than female rats

Tomasz Śledziński, Agnieszka Mirowska, Jerzy Klimek
Endokrynologia Polska 2011;62(4):331-334.

open access

Vol 62, No 4 (2011)
Original papers
Published online: 2011-08-30
Submitted: 2013-02-15

Abstract

Background: 11-β-hydroxysteroid dehydrogenase type I (11-β-HSD1) in the white adipose tissue (WAT) of rats catalyses the conversion of 11-dehydrocorticosterone to corticosterone, a more active glucocorticosteroid. Glucocorticosteroids in WAT stimulate adipocytes differentiation and increase adipocytes size. The aim of this study was to examine the association between expression of 11-β-HSD1 in the WAT of male and female rats and adipose tissue mass as well as body mass.
Material and methods: Perirenal WAT from male and female Wistar rats aged three months, and ovariectomized females of the same age, was used in the study. 11-β-HSD1 gene expression was assayed in the perirenal WAT of rats by real-time PCR.
Results: 11-β-HSD1 gene expression in the perirenal WAT of male rats was higher than in female rats. The WAT and body mass of male rats was also higher than in females. 11-β-HSD1 gene expression in the perirenal WAT as well as WAT mass and body mass increased simultaneously after ovariectomy.
Conclusions: The results presented in this paper suggest that higher 11betaHSD1 gene expression in the WAT is associated with higher body and adipose tissue mass. Moreover, our results suggest that oestradiol can modulate 11-β-HSD1 gene expression in the WAT of rats.
(Pol J Endocrinol 2011; 62 (4): 331–334)

Abstract

Background: 11-β-hydroxysteroid dehydrogenase type I (11-β-HSD1) in the white adipose tissue (WAT) of rats catalyses the conversion of 11-dehydrocorticosterone to corticosterone, a more active glucocorticosteroid. Glucocorticosteroids in WAT stimulate adipocytes differentiation and increase adipocytes size. The aim of this study was to examine the association between expression of 11-β-HSD1 in the WAT of male and female rats and adipose tissue mass as well as body mass.
Material and methods: Perirenal WAT from male and female Wistar rats aged three months, and ovariectomized females of the same age, was used in the study. 11-β-HSD1 gene expression was assayed in the perirenal WAT of rats by real-time PCR.
Results: 11-β-HSD1 gene expression in the perirenal WAT of male rats was higher than in female rats. The WAT and body mass of male rats was also higher than in females. 11-β-HSD1 gene expression in the perirenal WAT as well as WAT mass and body mass increased simultaneously after ovariectomy.
Conclusions: The results presented in this paper suggest that higher 11betaHSD1 gene expression in the WAT is associated with higher body and adipose tissue mass. Moreover, our results suggest that oestradiol can modulate 11-β-HSD1 gene expression in the WAT of rats.
(Pol J Endocrinol 2011; 62 (4): 331–334)
Get Citation

Keywords

11-beta-hydroxysteroid dehydrogenase type I; corticosterone; adipose tissue mass

About this article
Title

Higher 11-beta-hydroxysteroid dehydrogenase type I gene expression in white adipose tissue in male than female rats

Journal

Endokrynologia Polska

Issue

Vol 62, No 4 (2011)

Pages

331-334

Published online

2011-08-30

Bibliographic record

Endokrynologia Polska 2011;62(4):331-334.

Keywords

11-beta-hydroxysteroid dehydrogenase type I
corticosterone
adipose tissue mass

Authors

Tomasz Śledziński
Agnieszka Mirowska
Jerzy Klimek

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl